QT Interval Prolongation Is a Novel Predictor of 1-Year Mortality in Patients With COVID-19 Infection

BackgroundQT interval prolongation is common in critically ill patients and is associated with increased mortality. However, the predictive value of a prolonged corrected QT interval (QTc) for myocardial injury and long-term mortality among patients hospitalized with COVID-19 infection is not well k...

Full description

Bibliographic Details
Main Authors: Ariel Banai, Yishay Szekely, Lior Lupu, Ariel Borohovitz, Erez Levi, Eihab Ghantous, Philippe Taieb, Aviram Hochstadt, Shmuel Banai, Yan Topilsky, Ehud Chorin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.869089/full
_version_ 1818238697717366784
author Ariel Banai
Yishay Szekely
Lior Lupu
Ariel Borohovitz
Erez Levi
Eihab Ghantous
Philippe Taieb
Aviram Hochstadt
Shmuel Banai
Yan Topilsky
Ehud Chorin
author_facet Ariel Banai
Yishay Szekely
Lior Lupu
Ariel Borohovitz
Erez Levi
Eihab Ghantous
Philippe Taieb
Aviram Hochstadt
Shmuel Banai
Yan Topilsky
Ehud Chorin
author_sort Ariel Banai
collection DOAJ
description BackgroundQT interval prolongation is common in critically ill patients and is associated with increased mortality. However, the predictive value of a prolonged corrected QT interval (QTc) for myocardial injury and long-term mortality among patients hospitalized with COVID-19 infection is not well known.PurposeTo evaluate the association of prolonged QTc with myocardial injury and with 1-year mortality among patients hospitalized with COVID-19 infection.Materials and MethodsA total of 335 consecutive patients hospitalized with COVID-19 infection were prospectively studied. All patients underwent a comprehensive echocardiographic evaluation within 48 h from admission. Using the Bazett formula, the QTc interval was calculated from the first ECG tracing recorded at the ER. QTc ≥ 440 ms in males and ≥450 ms in females was considered prolonged. Patients with elevated cardiac biomarkers and/or echocardiographic signs of myocardial dysfunction were considered to have myocardial injury. The predictive value of QTc prolongation for myocardial injury was calculated using a multivariate binary regression model. One-year mortality rate of patients with and without QTc prolongation was compared using the log-rank test, and a multivariate Cox regression model adjusting for multiple covariates was performed to evaluate the 1-year mortality risk.ResultsOne-hundred and nine (32.5%) patients had a prolonged QTc. Compared to patients without QTc prolongation, patients with prolonged QTc were older (70 ± 14.4 vs. 62.7 ± 16.6, p < 0.001), had more comorbidities, and presented with a more severe disease. Prolonged QTc was an independent predictor for severe or critical disease (adjusted HR 2.14, 95% CI 1.3–3.5; p = 0.002) and myocardial injury (adjusted HR 2.07, 95% CI 1.22–3.5; p = 0.007). One-year mortality of patients with prolonged QTc was higher than those with no QTc prolongation (40.4% vs. 15.5; p < 0.001). Following adjustment to multiple covariates including myocardial injury and disease severity, QTc prolongation was found to be associated with increased 1-year mortality risk (HR 1.69, 95% CI 1.06–2.68, p = 0.027).ConclusionProlonged QTc is associated with disease severity, myocardial injury and 1-year mortality among patients hospitalized with COVID-19 infection.
first_indexed 2024-12-12T12:45:47Z
format Article
id doaj.art-b424126baffe413194a7c4c4fabf10bd
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-12T12:45:47Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-b424126baffe413194a7c4c4fabf10bd2022-12-22T00:24:07ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-06-01910.3389/fcvm.2022.869089869089QT Interval Prolongation Is a Novel Predictor of 1-Year Mortality in Patients With COVID-19 InfectionAriel BanaiYishay SzekelyLior LupuAriel BorohovitzErez LeviEihab GhantousPhilippe TaiebAviram HochstadtShmuel BanaiYan TopilskyEhud ChorinBackgroundQT interval prolongation is common in critically ill patients and is associated with increased mortality. However, the predictive value of a prolonged corrected QT interval (QTc) for myocardial injury and long-term mortality among patients hospitalized with COVID-19 infection is not well known.PurposeTo evaluate the association of prolonged QTc with myocardial injury and with 1-year mortality among patients hospitalized with COVID-19 infection.Materials and MethodsA total of 335 consecutive patients hospitalized with COVID-19 infection were prospectively studied. All patients underwent a comprehensive echocardiographic evaluation within 48 h from admission. Using the Bazett formula, the QTc interval was calculated from the first ECG tracing recorded at the ER. QTc ≥ 440 ms in males and ≥450 ms in females was considered prolonged. Patients with elevated cardiac biomarkers and/or echocardiographic signs of myocardial dysfunction were considered to have myocardial injury. The predictive value of QTc prolongation for myocardial injury was calculated using a multivariate binary regression model. One-year mortality rate of patients with and without QTc prolongation was compared using the log-rank test, and a multivariate Cox regression model adjusting for multiple covariates was performed to evaluate the 1-year mortality risk.ResultsOne-hundred and nine (32.5%) patients had a prolonged QTc. Compared to patients without QTc prolongation, patients with prolonged QTc were older (70 ± 14.4 vs. 62.7 ± 16.6, p < 0.001), had more comorbidities, and presented with a more severe disease. Prolonged QTc was an independent predictor for severe or critical disease (adjusted HR 2.14, 95% CI 1.3–3.5; p = 0.002) and myocardial injury (adjusted HR 2.07, 95% CI 1.22–3.5; p = 0.007). One-year mortality of patients with prolonged QTc was higher than those with no QTc prolongation (40.4% vs. 15.5; p < 0.001). Following adjustment to multiple covariates including myocardial injury and disease severity, QTc prolongation was found to be associated with increased 1-year mortality risk (HR 1.69, 95% CI 1.06–2.68, p = 0.027).ConclusionProlonged QTc is associated with disease severity, myocardial injury and 1-year mortality among patients hospitalized with COVID-19 infection.https://www.frontiersin.org/articles/10.3389/fcvm.2022.869089/fullQTc intervalmortalityCOVID-19myocardial injuryECG
spellingShingle Ariel Banai
Yishay Szekely
Lior Lupu
Ariel Borohovitz
Erez Levi
Eihab Ghantous
Philippe Taieb
Aviram Hochstadt
Shmuel Banai
Yan Topilsky
Ehud Chorin
QT Interval Prolongation Is a Novel Predictor of 1-Year Mortality in Patients With COVID-19 Infection
Frontiers in Cardiovascular Medicine
QTc interval
mortality
COVID-19
myocardial injury
ECG
title QT Interval Prolongation Is a Novel Predictor of 1-Year Mortality in Patients With COVID-19 Infection
title_full QT Interval Prolongation Is a Novel Predictor of 1-Year Mortality in Patients With COVID-19 Infection
title_fullStr QT Interval Prolongation Is a Novel Predictor of 1-Year Mortality in Patients With COVID-19 Infection
title_full_unstemmed QT Interval Prolongation Is a Novel Predictor of 1-Year Mortality in Patients With COVID-19 Infection
title_short QT Interval Prolongation Is a Novel Predictor of 1-Year Mortality in Patients With COVID-19 Infection
title_sort qt interval prolongation is a novel predictor of 1 year mortality in patients with covid 19 infection
topic QTc interval
mortality
COVID-19
myocardial injury
ECG
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.869089/full
work_keys_str_mv AT arielbanai qtintervalprolongationisanovelpredictorof1yearmortalityinpatientswithcovid19infection
AT yishayszekely qtintervalprolongationisanovelpredictorof1yearmortalityinpatientswithcovid19infection
AT liorlupu qtintervalprolongationisanovelpredictorof1yearmortalityinpatientswithcovid19infection
AT arielborohovitz qtintervalprolongationisanovelpredictorof1yearmortalityinpatientswithcovid19infection
AT erezlevi qtintervalprolongationisanovelpredictorof1yearmortalityinpatientswithcovid19infection
AT eihabghantous qtintervalprolongationisanovelpredictorof1yearmortalityinpatientswithcovid19infection
AT philippetaieb qtintervalprolongationisanovelpredictorof1yearmortalityinpatientswithcovid19infection
AT aviramhochstadt qtintervalprolongationisanovelpredictorof1yearmortalityinpatientswithcovid19infection
AT shmuelbanai qtintervalprolongationisanovelpredictorof1yearmortalityinpatientswithcovid19infection
AT yantopilsky qtintervalprolongationisanovelpredictorof1yearmortalityinpatientswithcovid19infection
AT ehudchorin qtintervalprolongationisanovelpredictorof1yearmortalityinpatientswithcovid19infection